PharmaCyte Biotech (PMCB) Stock Price, Quote, News & History

PharmaCyte Biotech Inc (PMCB) Stock Price, Quote, News & History

PMCBNASDAQ

Trade with Public

$0.7204

0.02042.91%

Last update: Mar 19, 10:20 AM

Key Statistics

Open

$0.72

Volume / Avg.

31.89K / 270.76K

Day Range

$0.72 - $0.75

52 Wk Range

0.63 - 1.73

Market Cap

$7.30M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.25%

Days to Cover

1.06

Recent PharmaCyte Biotech Inc News

PRO
PharmaCyte Biotech Receives Noncompliance Notice From Nasdaq; Has Until June 2026 To Regain Compliance

On December 1, 2025, PharmaCyte Biotech, Inc. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the

Benzinga Newsdesk

PRO
PharmaCyte Biotech shares are trading higher after the company announced monetization of its stake in Femasys.

Benzinga Newsdesk

PRO
PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY

PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 percent decrease over earnings of $1.90 per share from the same period last year.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.52M

Investing Cash Flow (TTM)

-3.00M

Financing Cash Flow (TTM)

2.09M

Free Cash Flow (TTM)

-4.52M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-5.43M

Valuation Metrics

Enterprise Value

-$6.99M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.22

Earnings Yield % (TTM)

-154.49%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$3.32

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$15.41M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.72

Volume / Avg.

31.89K / 270.76K

Day Range

$0.72 - $0.75

52 Wk Range

0.63 - 1.73

Market Cap

$7.30M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.25%

Days to Cover

1.06

About

Sector

Health Care

Industry

Biotechnology

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy PharmaCyte Biotech (PMCB) stock?

You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.

View our list of the best stock brokerages

Who are PharmaCyte Biotech (PMCB) competitors?

Other companies in PharmaCyte Biotech’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), AIxCrypto Holdings Inc (NASDAQ:AIXC) and CollPlant Biotechnologies Ltd (NASDAQ:CLGN).

What is the forecast, or price target, for PharmaCyte Biotech (PMCB) stock?

There is no analysis for PharmaCyte Biotech to provide a consensus price target.

What is the current price for PharmaCyte Biotech (PMCB)?

The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $0.7204 last updated March 19, 2026 at 10:20 AM EDT.

Does PharmaCyte Biotech (PMCB) pay a dividend?

There are no upcoming dividends for PharmaCyte Biotech.

When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?

PharmaCyte Biotech does not have any upcoming earnings scheduled.

Is PharmaCyte Biotech (PMCB) going to split?

There is no upcoming split for PharmaCyte Biotech.

What sector and industry does PharmaCyte Biotech (PMCB) operate in?

PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ernexa Therapeutics Inc

AIxCrypto Holdings Inc

NASDAQ:AIXC

$1.30

-7.14%

CollPlant Biotechnologies Ltd

NASDAQ:CLGN

$0.61

No data available

Alaunos Therapeutics Inc

NASDAQ:TCRT

$3.27

No data available

Theriva Biologics Inc

AMEX:TOVX

$0.18

-1.10%

XTL Biopharmaceuticals Ltd

Key Statistics

Open

$0.72

Volume / Avg.

31.89K / 270.76K

Day Range

$0.72 - $0.75

52 Wk Range

0.63 - 1.73

Market Cap

$7.30M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.25%

Days to Cover

1.06

Recent PharmaCyte Biotech Inc News

PRO
PharmaCyte Biotech Receives Noncompliance Notice From Nasdaq; Has Until June 2026 To Regain Compliance

Benzinga Newsdesk

PRO
PharmaCyte Biotech shares are trading higher after the company announced monetization of its stake in Femasys.

Benzinga Newsdesk

PRO
PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY

PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 percent decrease over earnings of $1.90 per share from the same period last year.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.52M

Investing Cash Flow (TTM)

-3.00M

Financing Cash Flow (TTM)

2.09M

Free Cash Flow (TTM)

-4.52M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-5.43M

Valuation Metrics

Enterprise Value

-$6.99M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.22

Earnings Yield % (TTM)

-154.49%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$3.32

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$15.41M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.72

Volume / Avg.

31.89K / 270.76K

Day Range

$0.72 - $0.75

52 Wk Range

0.63 - 1.73

Market Cap

$7.30M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.25%

Days to Cover

1.06

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry